This innovative ECHO series is designed to empower healthcare professionals with comprehensive, evidence-based knowledge and skills for the diagnosis, management, and treatment of obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Recognizing that both conditions are highly prevalent and require specialized expertise for optimal patient care, this program seeks to bridge these critical gaps in understanding and practice.
Our primary objective is to significantly enhance your understanding of obesity as a chronic disease and its intricate relationship with MASLD. By offering education on these crucial factors through interprofessional, case-based learning, this program will significantly enhance participants’ ability to deliver high-quality, integrated care. This approach is vital for optimizing patient outcomes and effectively addressing the complex metabolic aspects of these prevalent conditions, ultimately improving overall patient health and managing disease progression.
After participating in ECHO, providers will be able to:
To view the CE Accreditation for CME, CNE, CPE, and Social Work credits, click here.
Provided by Rutgers Project ECHO & supported by an educational grant from Novo Nordisk.
© 2023 All rights reserved
Rutgers Project ECHO is administered by Rutgers Robert Wood Johnson Medical School with generous support from NJ Department of Health, NJ Department Human Services, and other funders.